- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.07. | Cannabis Bioscience International Holdings: CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research | 228 | Newsfile | Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare... ► Artikel lesen | |
| 15.07. | Cannabis Bioscience International Holdings: Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products | 250 | Newsfile | Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| CANNABIS BIOSCIENCE INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 06.07. | Cannabis Bioscience International Holdings: CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings | 328 | Newsfile | Houston, Texas--(Newsfile Corp. - July 6, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announces... ► Artikel lesen | |
| 22.06. | Cannabis Bioscience International Holdings: Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement | 273 | Newsfile | Houston, Texas--(Newsfile Corp. - June 22, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 15.06. | Cannabis Bioscience International Holdings: CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research | 353 | Newsfile | Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter... ► Artikel lesen | |
| 08.06. | Cannabis Bioscience International Holdings: CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers | 293 | Newsfile | Houston, Texas--(Newsfile Corp. - June 8, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public biotechnology company trading under the ticker symbol CBIH, today announced... ► Artikel lesen | |
| 01.06. | Cannabis Bioscience International Holdings: CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation | 237 | Newsfile | Houston, Texas--(Newsfile Corp. - June 1, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company focused on cannabinoid biotechnology, applied research, and therapeutic... ► Artikel lesen | |
| 16.04. | Cannabis Bioscience International Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.04. | Cannabis Bioscience International Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 12.01. | Cannabis Bioscience International Holdings: CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence | 306 | Newsfile | Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced... ► Artikel lesen | |
| 05.01. | Cannabis Bioscience International Holdings: CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition | 323 | Newsfile | Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 29.12.25 | Cannabis Bioscience International Holdings: CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways | 459 | Newsfile | Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 22.12.25 | Cannabis Bioscience International Holdings: CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities | 376 | Newsfile | Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications... ► Artikel lesen | |
| 13.10.25 | Cannabis Bioscience International Holdings: CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery | 477 | Newsfile | Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 43,770 | +2,77 % | Bayer Aktie unter Druck: Unterstützung gebrochen, Milliarden für die USA | Für die Bayer Aktie reißt die Schwäche nicht ab. Am Freitag rutschte der Kurs des Leverkusener Pharma- und Agrarkonzerns um 0,46 Euro oder 1,01 Prozent auf 44,94 Euro und bestätigte damit auf Schlusskursbasis... ► Artikel lesen | |
| MERCK KGAA | 137,85 | +1,58 % | Merck-Aktie mit Kurssprung: Dieser Milliarden-Deal bringt die Branche in Bewegung | Die Merck-Aktie legt am Dienstag kräftig zu. Der Kurs steigt auf rund 141,40 Euro und liegt damit zeitweise knapp 4,2 Prozent im Plus. Auslöser ist allerdings keine neue Nachricht aus dem Merck-Konzern... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 41,065 | +0,01 % | Wenn Mental Load zur Belastung wird / Neue Umfrage + praktischer Alltagshelfer von ratiopharm | Ulm (ots) - Der Alltag gleicht oft einer endlosen To-Do Liste: Arzttermine vereinbaren, den Wocheneinkauf planen und nebenbei noch einen Geburtstag organisieren. Diese ständige gedankliche Planungsarbeit... ► Artikel lesen | |
| NOVO NORDISK | 34,420 | +0,07 % | 23,3 Prozent Gewichtsverlust: Eli Lilly übertrifft den eigenen Blockbuster - das nächste Milliardenrennen hat bereits begonnen | ||
| LB PHARMACEUTICALS | 37,220 | 0,00 % | LB Pharmaceuticals stellt Daten zu LB-102 auf ECNP-Kongress vor | ||
| GENERATE BIOMEDICINES | 14,340 | 0,00 % | Generate Biomedicines, Inc.: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of 'Armored' CAR T Therapy for Ovarian Cancer | Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical... ► Artikel lesen | |
| PFIZER | 25,215 | -0,10 % | BERENBERG stuft PFIZER INC auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Pfizer auf "Hold" mit einem Kursziel von 25 US-Dollar belassen. Auf dem jährlichen Esmo-Krebskongress ab dem 23. Oktober in Madrid erwarte sie... ► Artikel lesen | |
| ZHENGYE BIOTECHNOLOGY | 1,730 | 0,00 % | Morning Market Movers: Zhengye Biotechnology, Lisata Therapeutics, Meiwu Technology, Danaher Corporation See Big Swings | WASHINGTON (dpa-AFX) - At 9:00 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| RETENSION PHARMACEUTICALS | 11,010 | +4,56 % | Retension Pharmaceuticals Announces Pricing of Initial Public Offering | FALLS CHURCH, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (Nasdaq: RTSN) ("Retension" or the "Company"), a clinical-stage biopharmaceutical company focused on developing... ► Artikel lesen | |
| SCHOTT PHARMA | 23,500 | -4,67 % | AKTIEN IM FOKUS: Aktien aus Diagnostik- und Laborbranche gesucht | FRANKFURT (dpa-AFX) - Aktien aus dem Segment Wirkstoffforschung, Diagnostik und Laborausrüstung haben am Dienstag auf den Kauflisten von Anlegern gestanden. Den Dax führten die Papiere von Qiagen und... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 55,20 | -0,02 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| KARDIGAN | 14,670 | 0,00 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| GSK | 20,710 | +1,02 % | Eli Lilly gibt 32 Milliarden Dollar für Zukäufe aus: Wo steht Emyria im globalen Biotech-Kaufrausch? | ||
| AQUESTIVE THERAPEUTICS | 4,780 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film | Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable... ► Artikel lesen | |
| OMNIAB | 4,790 | 0,00 % | StoneX raises OmniAb stock price target to $6 on new products |
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS INC finden Sie auf Wallstreet Online.